Artrya (ASX:AYA) Short-Term Capital Lease Obligation : A$0.00 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Artrya Short-Term Capital Lease Obligation?

Artrya's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was A$0.00 Mil.

Artrya's quarterly Short-Term Capital Lease Obligation increased from Dec. 2023 (A$0.00 Mil) to Jun. 2024 (A$0.33 Mil) but then declined from Jun. 2024 (A$0.33 Mil) to Dec. 2024 (A$0.00 Mil).

Artrya's annual Short-Term Capital Lease Obligation increased from Jun. 2022 (A$0.22 Mil) to Jun. 2023 (A$0.28 Mil) and increased from Jun. 2023 (A$0.28 Mil) to Jun. 2024 (A$0.33 Mil).

Artrya Short-Term Capital Lease Obligation Historical Data

The historical data trend for Artrya's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artrya Short-Term Capital Lease Obligation Chart

Artrya Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

Short-Term Capital Lease Obligation

0.04

0.22

0.28

0.33

Artrya Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial			-	0.28	-	0.33	-

Artrya Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Artrya Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Artrya's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Artrya Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Artrya Ltd (ASX:AYA) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

1257 Hay Street, West Perth, Perth, WA, AUS, 6005

Website

https://www.artrya.com

Artrya Ltd is a medical technology company. It is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. The company is managed based on a single segment, being the development of AI-driven CCTA image analysis technology.

Artrya Headlines

No Headlines